Development and pharmacokinetics of nimodipine-loaded liposomes
- 1 September 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 58 (9) , 1289-1294
Abstract
In order to improve the water solubility of nimodipine and prolong the time of the drug in the circulation, nimodipine-loaded liposomes with a small size and high entrapment efficiency were prepared by a method that was easy to scale up (the modified ethanol injection method). The nimodipine liposome dispersions were characterized with respect to particle size distribution, zeta potential and entrapment efficiency. Liposomal nimodipine and nimodipine solution were intravenously administered to mice as a single dose of 4 mg kg−1. The pharmacokinetic parameters of nimodipine changed significantly when encapsulated in liposomes. The clearance of nimodipine encapsulated in liposomes was reduced and the elimination half-life was prolonged. The ratios of the area under the curve values of nimodipine liposomes to nimodipine solution were 1.78 and 1.90 in plasma and cerebral tissue, respectively. The drug concentration in cerebral tissue and in plasma showed a good linear correlation, which showed that liposomes could efficiently deliver nimodipine into brain tissue. These findings suggest that intravenous administration of liposomal nimodipine produces higher and more stable plasma and cerebral drug concentrations compared with nimodipine solution. In conclusion, liposomal nimodipine is a promising alternative to the solution preparation.Keywords
This publication has 6 references indexed in Scilit:
- Preparation, Characterization, and Pharmacokinetics of Sterically Stabilized Nimodipine-Containing LiposomesDrug Development and Industrial Pharmacy, 2006
- Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomesInternational Journal of Pharmaceutics, 2005
- Rate of biodistribution of STEALTH® liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Nimodipine: Drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemiaClinical Pharmacology & Therapeutics, 2002
- Nimodipine in the treatment of old age dementiasProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1990
- NimodipineDrugs, 1989